Search Results - "DiSilvestro, P. A."

Cytoreductive surgery for ovarian cancer: quality assessment by Brand, A H, DiSilvestro, P A, Sehouli, J, Berek, J S

“…Surgery is the cornerstone of treatment of ovarian cancer. Given the importance of achieving no or minimal macroscopic residual disease at primary surgery,…”
Get full text

Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe by Van der Kolk, W.L., Van der Zee, A.G.J., Slomovitz, B.M., Baldwin, P.J.W., Van Doorn, H.C., De Hullu, J.A., Van der Velden, J., Gaarenstroom, K.N., Slangen, B.F.M., Kjolhede, P., Brännström, M., Vergote, I., Holland, C.M., Coleman, R., Van Dorst, E.B.L., Van Driel, W.J., Nunns, D., Widschwendter, M., Nugent, D., DiSilvestro, P.A., Mannel, R.S., Tjiong, M.Y., Boll, D., Cibula, D., Covens, A., Provencher, D., Runnebaum, I.B., Monk, B.J., Zanagnolo, V., Tamussino, K., Oonk, M.H.M., Levenback, C.F., Hermans, R.H., Bouda, J., Sharma, A., Luesley, D., Ellis, P., Cruickshank, D.J., Duncan, T.J., Kieser, K., Palle, C., Spirtos, N.M., O'Malley, D.M., Leitao, M.M., Geller, M., Dhar, K., Asher, V., Tobias, D.H., Borgfeldt, C., Lea, J.S., Lood, M., Bailey, J., Eyjolfsdottir, B., Attard-Montalto, S., Tewari, K.S., Persson, P., Manchanda, R., Jensen, P., Van Le, L.

“…OBJECTIVEOptimal management of the contralateral groin in patients with early-stage vulvar squamous cell carcinoma (VSCC) and a metastatic unilateral inguinal…”
Get full text

HE4 suppresses the expression of osteopontin in mononuclear cells and compromises their cytotoxicity against ovarian cancer cells by James, N. E., Cantillo, E., Oliver, M. T., Rowswell‐Turner, R. B., Ribeiro, J. R., Kim, K.‐K., Chichester, C. O., DiSilvestro, P. A., Moore, R. G., Singh, R. K., Yano, N., Zhao, T. C.

“…Summary Ovarian cancers are known to evade immunosurveillance and to orchestrate a suppressive immune microenvironment. Here we examine the role of human…”
Get full text

Urinary symptoms and impact on quality of life in women after treatment for endometrial cancer by Erekson, E. A., Sung, V. W., DiSilvestro, P. A., Myers, D. L.

“…The primary objective of our study is to describe urinary symptoms in women treated for endometrial cancer. We performed a cross-sectional survey of women who…”
Get full text

Lower uterine segment involvement as a predictor for lymph node spread in endometrial carcinoma by Madom, L.M, Brown, A.K, Lui, F, Moore, R.G, Granai, C.O, Disilvestro, P.A

“…Abstract Objectives. Several predictive factors for lymph node spread in endometrial cancer have been identified including tumor grade, depth of invasion,…”
Get full text

Malignant mixed mesodermal tumors of the ovary by DiSilvestro, Paul A., Gajewski, Walter H., Ludwig, Mark E., Kourea, Helen, Sung, James, Granai, C.O.

“…To review the experience at Women & Infants Hospital and Hartford Hospital of patients with malignant mixed mesodermal tumors of the ovary, and to review the…”
Get full text

Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer by Coleman, Robert L, Fleming, Gini F, Brady, Mark F, Swisher, Elizabeth M, Steffensen, Karina D, Friedlander, Michael, Okamoto, Aikou, Moore, Kathleen N, Efrat Ben-Baruch, Noa, Werner, Theresa L, Cloven, Noelle G, Oaknin, Ana, DiSilvestro, Paul A, Morgan, Mark A, Nam, Joo-Hyun, Leath, Charles A, Nicum, Shibani, Hagemann, Andrea R, Littell, Ramey D, Cella, David, Baron-Hay, Sally, Garcia-Donas, Jesus, Mizuno, Mika, Bell-McGuinn, Katherine, Sullivan, Danielle M, Bach, Bruce A, Bhattacharya, Sudipta, Ratajczak, Christine K, Ansell, Peter J, Dinh, Minh H, Aghajanian, Carol, Bookman, Michael A

“…The addition of veliparib, a PARP inhibitor, to induction chemotherapy and maintenance therapy in women with advanced ovarian cancer significantly improved…”
Get full text

Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer by Chan, John K, Brady, Mark F, Penson, Richard T, Huang, Helen, Birrer, Michael J, Walker, Joan L, DiSilvestro, Paul A, Rubin, Stephen C, Martin, Lainie P, Davidson, Susan A, Huh, Warner K, O’Malley, David M, Boente, Matthew P, Michael, Helen, Monk, Bradley J

“…The dose-dense delivery of chemotherapy (greater frequency of drug delivery) was explored in women with advanced ovarian cancer. All patients received…”
Get full text

1052PDisparities starting adjuvant chemotherapy for locally advanced cervix cancer in the international, academic, randomised, phase III OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274) by Mileshkin, L, Barnes, E, Moore, K N, Gebski, V, King, M, Narayan, K, Kolodziej, I K, Sjoquist, K, Fyles, A, Small, W, Gaffney, D, Quinn, M, Andrews, J, Thompson, S, Huh, W, Carlson, M, Disilvestro, P A, Rischin, D, Stockler, M R, Monk, B J

“…Abstract Background OUTBACK is testing the addition of 4 cycles of adjuvant carboplatin/paclitaxel chemotherapy (chemo) after definitive chemoradiation in…”
Get full text

Panniculectomy in morbidly obese gynecologic oncology patients by Pearl, M L, Valea, F A, Disilvestro, P A, Chalas, E

“…It is clear that morbid obesity presents a serious risk to women undergoing major intra-abdominal gynecologic surgery. Unfortunately, many gynecologic…”
Get more information

A phase 1b study of the nanoparticle-drug conjugate (NDC) CRLX101 in combination with weekly paclitaxel in patients (pts) with platinum-resistant ovarian cancer (OC) by Krasner, C.N., Schilder, R.J., Brady, W.E., Duska, L.R., O'Malley, D., Disilvestro, P.A., Li, J., Downing, W., Senderowicz, A.

Get full text

Cytoreductive surgery for ovarian cancer: quality assessment by Brand, A H, DiSilvestro, P A, Sehouli, J, Berek, J S

“…Surgery is the cornerstone of treatment of ovarian cancer. Given the importance of achieving no or minimal macroscopic residual disease at primary surgery,…”
Get full text

Phase II trial of pegylated liposomal doxorubicin as consolidation chemotherapy in patients with stage III or IV ovarian or primary peritoneal carcinoma by Disilvestro, P. A., Fisher, M., Pearl, M., Valea, F., Buhl, A., Chalas, E.

“…Abstract only…”
Get full text

Phase II trial of pegylated liposomal doxorubicin as consolidation chemotherapy in patients with stage III or IV ovarian or primary peritoneal carcinoma by Disilvestro, P. A., Fisher, M., Pearl, M., Valea, F., Buhl, A., Chalas, E.

“…Abstract only…”
Get full text

Does body mass index predict cutaneous reactions to pegylated liposomal doxorubicin? by Fleming, E. L., Dizon, D. S., Disilvestro, P. A., Moore, R. G., Granai, C., Gordinier, M. E.

“…Abstract only…”
Get full text

Does body mass index predict cutaneous reactions to pegylated liposomal doxorubicin? by Fleming, E. L., Dizon, D. S., Disilvestro, P. A., Moore, R. G., Granai, C., Gordinier, M. E.

“…Abstract only…”
Get full text

'You may think I'm too old, but can't you treat my cancer?' by DiSilvestro, P A, Granai, C O, Gajewski, W H, Falkenberry, S S

Get more information

Ovarian cancer? What is the next step? by Granai, C O, Gajewski, W H, DiSilvestro, P A, Falkenberry, S S

Get more information

A randomized controlled trial of a regular diet as the first meal in gynecologic oncology patients undergoing intraabdominal surgery by Pearl, Michael L, Frandina, Martina, Mahler, Linda, Valea, Fidel A, DiSilvestro, Paul A, Chalas, Eva

“…OBJECTIVE: To prospectively evaluate the safety and efficacy of a regular diet as the first meal after intraabdominal surgery in gynecologic oncology patients…”
Get full text

Treatment of Cervical Intraepithelial Neoplasia Levels 2 and 3 with Adapalene, a Retinoid‐Related Molecule by DiSilvestro, Paul A., DiSilvestro, Julianna M., Lernhardt, Waldemar, Pfahl, Magnus, Mannel, Robert S.

“…Objectives. This study examined dose scheduling, safety, and efficacy of adapalene in the treatment of CIN2 and CIN3. Methods. Patients were instructed on…”
Get full text